IL145891A0 - Methods and compositions for modulating an immune response - Google Patents
Methods and compositions for modulating an immune responseInfo
- Publication number
- IL145891A0 IL145891A0 IL14589100A IL14589100A IL145891A0 IL 145891 A0 IL145891 A0 IL 145891A0 IL 14589100 A IL14589100 A IL 14589100A IL 14589100 A IL14589100 A IL 14589100A IL 145891 A0 IL145891 A0 IL 145891A0
- Authority
- IL
- Israel
- Prior art keywords
- modulating
- compositions
- methods
- immune response
- immune
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12977299P | 1999-04-15 | 1999-04-15 | |
PCT/US2000/010340 WO2000063241A2 (en) | 1999-04-15 | 2000-04-17 | Methods and compositions for modulating an immune response |
Publications (1)
Publication Number | Publication Date |
---|---|
IL145891A0 true IL145891A0 (en) | 2002-07-25 |
Family
ID=22441531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14589100A IL145891A0 (en) | 1999-04-15 | 2000-04-17 | Methods and compositions for modulating an immune response |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1175223A2 (en) |
JP (1) | JP2003517284A (en) |
AU (1) | AU773350B2 (en) |
BR (1) | BR0009791A (en) |
CA (1) | CA2370129A1 (en) |
IL (1) | IL145891A0 (en) |
MX (1) | MXPA01010332A (en) |
WO (1) | WO2000063241A2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0101973D0 (en) * | 2001-01-25 | 2001-03-14 | Statens Seruminstitut | Improved in vitro diagnostic method of detecting a cell-mediated immune response |
JP2002221520A (en) * | 2001-01-29 | 2002-08-09 | Sumitomo Chem Co Ltd | Prediction method for immunology type |
US7202044B2 (en) | 2001-05-09 | 2007-04-10 | Biovision Ag | Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents |
EP1389130B1 (en) | 2001-05-17 | 2012-05-02 | Merck Serono SA | Use of osteopontin for the treatment and/or prevention of neurologic diseases |
GB0116185D0 (en) * | 2001-07-02 | 2001-08-22 | Imp College Innovations Ltd | Substances |
CA2461529A1 (en) | 2001-09-25 | 2003-04-03 | Immuno-Biological Laboratories Co., Ltd. | Recombinant anti-osteopontin antibody and use thereof |
EP1517695A4 (en) * | 2002-06-25 | 2010-09-01 | Aventis Pharma Inc | Osteopontin, oligodendrocytes and myelination |
WO2004013311A2 (en) | 2002-08-06 | 2004-02-12 | Diadexus, Inc. | Compositions and methods relating to ovarian specific genes and proteins |
JPWO2004103403A1 (en) * | 2003-05-23 | 2006-07-20 | 株式会社 免疫生物研究所 | Immunocompetent cell activation inhibitors and uses thereof |
WO2005100562A1 (en) * | 2004-04-12 | 2005-10-27 | Gene Techno Science Co., Ltd. | OSTEOPONTIN siRNA |
JP5399710B2 (en) * | 2006-10-26 | 2014-01-29 | 株式会社ジーンテクノサイエンス | Antibody against amino acid sequence RGD of extracellular matrix protein and its production and use |
CN101293916A (en) * | 2007-04-24 | 2008-10-29 | 上海国健生物技术研究院 | Monoclone antibody with combined function epiposition, specificity of osteopontin and uses thereof |
WO2009131256A1 (en) | 2008-04-24 | 2009-10-29 | Gene Techno Science Co., Ltd. | Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
JPWO2009147742A1 (en) * | 2008-06-06 | 2011-10-20 | 株式会社ジーンテクノサイエンス | Human osteopontin siRNA |
JP5781504B2 (en) | 2009-09-24 | 2015-09-24 | 株式会社ジーンテクノサイエンス | Humanized antibodies specific for the amino acid sequence RGD of extracellular matrix proteins and their use |
US20150344534A1 (en) * | 2011-12-07 | 2015-12-03 | Arla Foods Amba | Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants |
BR112016000067B1 (en) * | 2013-07-05 | 2022-08-30 | Arla Foods Amba | USE OF A BOVINE MILK OSTEOPONTINA AND USE OF A VACCINE SYSTEM |
WO2016112193A1 (en) * | 2015-01-07 | 2016-07-14 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of peptide-based inhibitors of the stat3-il10 pathway for treating bacterial infection and granulomatous disease |
KR20210005604A (en) | 2018-04-25 | 2021-01-14 | 헬쓰 앤드 해피니스 (에이치&에이치) 홍콩 리미티드 | Combination of osteopontin and 2'-fucosylactose for use in medicine |
CA3216462A1 (en) * | 2021-04-20 | 2022-10-27 | University Of Cincinnati | A vaccine adjuvant for infectious diseases |
CN115707772A (en) * | 2021-08-18 | 2023-02-21 | 澳门大学 | Inducer, macrophage and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998056405A1 (en) * | 1997-06-10 | 1998-12-17 | Whitehead Institute For Biomedical Research | A method of modulating immune response with osteopontin |
-
2000
- 2000-04-17 BR BR0009791-8A patent/BR0009791A/en not_active IP Right Cessation
- 2000-04-17 MX MXPA01010332A patent/MXPA01010332A/en unknown
- 2000-04-17 EP EP00923454A patent/EP1175223A2/en not_active Withdrawn
- 2000-04-17 AU AU43575/00A patent/AU773350B2/en not_active Ceased
- 2000-04-17 CA CA002370129A patent/CA2370129A1/en not_active Abandoned
- 2000-04-17 IL IL14589100A patent/IL145891A0/en unknown
- 2000-04-17 JP JP2000612329A patent/JP2003517284A/en not_active Withdrawn
- 2000-04-17 WO PCT/US2000/010340 patent/WO2000063241A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1175223A2 (en) | 2002-01-30 |
CA2370129A1 (en) | 2000-10-26 |
JP2003517284A (en) | 2003-05-27 |
MXPA01010332A (en) | 2002-09-18 |
WO2000063241A3 (en) | 2001-05-10 |
AU4357500A (en) | 2000-11-02 |
BR0009791A (en) | 2002-01-08 |
WO2000063241A2 (en) | 2000-10-26 |
AU773350B2 (en) | 2004-05-20 |
WO2000063241A9 (en) | 2002-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145891A0 (en) | Methods and compositions for modulating an immune response | |
EP1176948A4 (en) | Anti-nausea compositions and methods | |
AUPQ419099A0 (en) | Novel compositions and methods | |
EP1196192A4 (en) | Method for enhancing an immune response | |
EP1030654A4 (en) | Omeprazole formulation | |
EP1107735A4 (en) | Omeprazole formulation | |
EP1061800A4 (en) | Compositions and methods for modulating vascularization | |
EP1056456A4 (en) | R-lansoprazole compositions and methods | |
IL143423A0 (en) | Insecticidal compositions and insecticidal methods | |
IL138207A0 (en) | Methods and devices for modulating the immune response | |
EP1056457A4 (en) | S-lansoprazole compositions and methods | |
AU7474100A (en) | Methods and compositions for reducing immune response | |
AU2002309486A8 (en) | Methods and compositions for modulating the immune system of animals | |
EP1073333A4 (en) | S-rabeprazole compositions and methods | |
AU2273397A (en) | Methods and compositions for modulating an immune response | |
PL343432A1 (en) | Methods and devices for modulating the immune response | |
GB9922135D0 (en) | Compositions and uses | |
GB0318112D0 (en) | ›-Secretase enzyme compositions and methods | |
IL140574A0 (en) | Methods and compositions for modulating spermatogenesis | |
AU2002248646A1 (en) | Compositions and methods for modulating an immune response | |
AU4866201A (en) | Compositions and methods for use in modulating immune system function | |
AU8513698A (en) | Methods and compositions for designing vaccines | |
AU8408798A (en) | Methods and compositions for inhibiting the proinflammatory response | |
EP1073332A4 (en) | R-rabeprazole compositions and methods | |
AU2945599A (en) | Immune response |